Gene · 3672
Papers3,336
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,336
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sequential actions of EOMES and T-BET promote stepwise maturation of natural killer cells. | Nat Commun | 2021 | 34521844 | PubTator, text mining | PubMed |
| Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue. | Sci Immunol | 2021 | 34519539 | PubTator, text mining | PubMed |
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE). | BMJ Open | 2021 | 34518264 | PubTator, text mining | PubMed |
| Effect of Tension on Human Periodontal Ligament Cells: Systematic Review and Network Analysis. | Front Bioeng Biotechnol | 2021 | 34513810 | PubTator, text mining | PubMed |
| Construction of Potential Gene Expression and Regulation Networks in Prostate Cancer Using Bioinformatics Tools. | Oxid Med Cell Longev | 2021 | 34512870 | PubTator, text mining | PubMed |
| Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications. | Front Immunol | 2021 | 34512661 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Promote Vascular Invasion of Hepatocellular Carcinoma via Downregulating Decorin-integrin β1 Signaling. | Front Cell Dev Biol | 2021 | 34504839 | PubTator, text mining | PubMed |
| Expression of CD49f defines subsets of human regulatory T cells with divergent transcriptional landscape and function that correlate with ulcerative colitis disease activity. | Clin Transl Immunology | 2021 | 34504692 | PubTator, text mining | PubMed |
| Pancreatic Lineage Specifier PDX1 Increases Adhesion and Decreases Motility of Cancer Cells. | Cancers (Basel) | 2021 | 34503200 | PubTator, text mining | PubMed |
| Skin-Resident Memory T Cells: Pathogenesis and Implication for the Treatment of Psoriasis. | J Clin Med | 2021 | 34501272 | PubTator, text mining | PubMed |
| Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review). | Oncol Rep | 2021 | 34498710 | PubTator, text mining | PubMed |
| Skin Resident Memory T Cells May Play Critical Role in Delayed-Type Drug Hypersensitivity Reactions. | Front Immunol | 2021 | 34497600 | PubTator, text mining | PubMed |
| Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response. | J Transl Med | 2021 | 34496872 | PubTator, text mining | PubMed |
| Genomics and metabolomics of early-stage thioacetamide-induced liver injury: An interspecies study between guinea pig and rat. | Toxicol Appl Pharmacol | 2021 | 34492290 | PubTator, text mining | PubMed |
| ABL1 Is a Prognostic Marker and Associated with Immune Infiltration in Hepatocellular Carcinoma. | J Oncol | 2021 | 34484330 | PubTator, text mining | PubMed |
| Dual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel disease. | Cell Rep Med | 2021 | 34467254 | PubTator, text mining | PubMed |
| Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues. | Nat Immunol | 2021 | 34462601 | PubTator, text mining | PubMed |
| Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment. | Pharmaceutics | 2021 | 34452256 | PubTator, text mining | PubMed |
| Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner. | Front Immunol | 2021 | 34447383 | PubTator, text mining | PubMed |
| Natural Killer Cells and Type 1 Innate Lymphoid Cells in Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. | Int J Mol Sci | 2021 | 34445750 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3672/papers?page=55